GoodRx Holdings Inc (GDRX) Stock: What the Analysts are Saying

The stock has a 36-month beta value of 1.42. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

The public float for GDRX is 76.60M, and at present, short sellers hold a 12.86% of that float. On April 04, 2024, the average trading volume of GDRX was 1.63M shares.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


GDRX) stock’s latest price update

GoodRx Holdings Inc (NASDAQ: GDRX) has experienced a decline in its stock price by -1.18 compared to its previous closing price of 6.80. However, the company has seen a fall of -4.82% in its stock price over the last five trading days. The Motley Fool reported 2024-03-25 that GoodRx got an upgrade from Wells Fargo. The analysts appreciate the company’s increased-revenue visibility.

GDRX’s Market Performance

GoodRx Holdings Inc (GDRX) has experienced a -4.82% fall in stock performance for the past week, with a -16.83% drop in the past month, and a 19.57% rise in the past quarter. The volatility ratio for the week is 3.58%, and the volatility levels for the past 30 days are at 5.32% for GDRX. The simple moving average for the last 20 days is -4.61% for GDRX’s stock, with a simple moving average of 7.23% for the last 200 days.

Analysts’ Opinion of GDRX

Many brokerage firms have already submitted their reports for GDRX stocks, with Wells Fargo repeating the rating for GDRX by listing it as a “Overweight.” The predicted price for GDRX in the upcoming period, according to Wells Fargo is $10 based on the research report published on March 25, 2024 of the current year 2024.

JP Morgan, on the other hand, stated in their research note that they expect to see GDRX reach a price target of $10, previously predicting the price at $7. The rating they have provided for GDRX stocks is “Overweight” according to the report published on March 01st, 2024.

Leerink Partners gave a rating of “Outperform” to GDRX, setting the target price at $8 in the report published on February 26th of the current year.

GDRX Trading at -0.79% from the 50-Day Moving Average

After a stumble in the market that brought GDRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.28% of loss for the given period.

Volatility was left at 5.32%, however, over the last 30 days, the volatility rate increased by 3.58%, as shares sank -11.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.28% upper at present.

During the last 5 trading sessions, GDRX fell by -4.82%, which changed the moving average for the period of 200-days by +16.26% in comparison to the 20-day moving average, which settled at $7.00. In addition, GoodRx Holdings Inc saw 0.30% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at GDRX starting from Wagner Scott, who purchase 21,652 shares at the price of $5.76 back on Nov 30 ’23. After this action, Wagner Scott now owns 182,900 shares of GoodRx Holdings Inc, valued at $124,806 using the latest closing price.

Wagner Scott, the of GoodRx Holdings Inc, purchase 26,348 shares at $5.90 during a trade that took place back on Nov 29 ’23, which means that Wagner Scott is holding 161,248 shares at $155,482 based on the most recent closing price.

Stock Fundamentals for GDRX

Current profitability levels for the company are sitting at:

  • -0.02 for the present operating margin
  • 0.85 for the gross margin

The net margin for GoodRx Holdings Inc stands at -0.01. The total capital return value is set at -0.01. Equity return is now at value -1.12, with -0.55 for asset returns.

Based on GoodRx Holdings Inc (GDRX), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at 0.87. The interest coverage ratio of the stock is -0.33.

Currently, EBITDA for the company is 163.15 million with net debt to EBITDA at 0.37. When we switch over and look at the enterprise to sales, we see a ratio of 3.59. The receivables turnover for the company is 4.69for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.12.


To sum up, GoodRx Holdings Inc (GDRX) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts